Total Funding
10
Total FundingPrivate Equity raised
Growth Score
pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
268824
Synteract®, a Syneos Health® company, is a leading full service CRO focused on the emerging biopharma segment.
Acquired by 
Syneos Health
Steve Powell: CEOPast Role: Exco InTouch, COO & President- Frank Santoro: Chief Medical Officer
About the Company
Synteract®, a Syneos Health® company, is a leading full service CRO focused on the emerging biopharma segment. The Company’s multidisciplinary teams support biotech and pharmaceutical companies across all phases of drug development, providing deep expertise in oncology, dermatology, general medicine, infectious disease and vaccine, neuroscience,
pediatrics, and rare and orphan diseases. Synteract has conducted nearly 4,000 studies on six continents in over 62 countries. To learn more about how Synteract is Bringing clinical trials to lifeTM by transforming insights to action and making therapies a reality, visit synteract.com and connect on LinkedIn and Twitter.
Women Founded
